Skip to main content

Andrew D'Silva

Equibles does not estimate personal net worth.

Get an email with a short summary when OptimizeRx Corp publishes a filing, an earnings call transcript or a press release.

Get OPRX alerts

About Andrew D'Silva

Andrew D'Silva is recorded as CFO at OptimizeRx Corp (OPRX) since January 1, 2027. OptimizeRx Corp reported in an 8-K filed August 12, 2026 that Andrew D'Silva was appointed Chief Financial Officer, effective January 1, 2027. OptimizeRx Corp is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at OptimizeRx Corp includes Stephen Silvestro (CEO and Board Member), William Febbo (CEO and Board Member), William J. Febbo (CEO and Board Member) and 7 others.

“Mr. Andrew D'Silva will become Chief Financial Officer and Ms. Heather Favazza will become Chief Accounting Officer, each effective January 1, 2027.”
OptimizeRx Corp Form 8-K, filed August 12, 2026 · Read the filing

Affiliation history

Company network

Current role

Health Information Services · Healthcare

CFO

2027-01-01–present

Leadership on record at OptimizeRx Corp

Recent activity